mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
about
Cancer-associated fibroblasts in hepatocellular carcinomaMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular CarcinomaHepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.Fibrolamellar hepatocellular carcinoma: current clinical perspectives.Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma.Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.FGFR1 and FGFR2 in fibrolamellar carcinoma.DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.Fibrolamellar hepatocellular carcinoma in ascitic fluid: A case report with cytohistological correlation.Fibroblast growth factor receptor 1 antagonism attenuates lipopolysaccharide-induced activation of hepatic stellate cells via suppressing inflammation
P2860
Q26738536-BF0F3E68-B9AB-407C-A7F8-C1B96225D904Q26998606-638B1C35-16E8-465E-A008-E565572BCC93Q28072292-45A491F5-8578-459F-9BE4-FAD4D44358CEQ36731897-213D75ED-2F1D-40D5-BC5F-0D29E0848F0FQ37031777-D4D58C6B-095D-447D-904C-EC84B48A2AA6Q37408965-C05370FE-3568-4E2F-AE2E-A0877C4F4324Q38901483-B7DAB705-36D2-4D95-BBD3-A50350000E1AQ40640497-0993949C-BEBF-407A-B295-F24FE1368DFAQ47377422-CD3BC447-DF7F-4D44-BBF8-FF617B1AE782Q48095053-549FE678-8E43-4DF3-9F8B-43E6C7A797B7Q52689575-56FA2428-1886-41CE-ABE3-D33FF8762819Q53095616-23AF91CD-8686-4979-99B7-4EA8A3238822Q58796655-C28EAA88-B189-4211-ACC8-4E8B226B70FE
P2860
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
@en
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
@nl
type
label
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
@en
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
@nl
prefLabel
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
@en
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
@en
P2093
Heidi L Kenerson
James O Park
Kimberly J Riehle
Matthew M Yeh
Raymond S Yeung
William P Harris
P2860
P2888
P304
P356
10.1038/MODPATHOL.2014.78
P577
2014-06-13T00:00:00Z
P5875
P6179
1032126699